Sverrisdottir, A <br/><br/>
Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial.  [electronic resource] 

 -  Breast cancer research and treatment  Oct 2009 
 - 561-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-7217 
<br/><br/><label>Standard No.: </label>10.1007/s10549-009-0313-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents, Hormonal--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Breast Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant<br/>Cyclophosphamide--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Goserelin--administration & dosage<br/>Humans<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Ovarian Function Tests<br/>Ovary--drug effects<br/>Premenopause<br/>Primary Ovarian Insufficiency--prevention & control<br/>Tamoxifen--administration & dosage